Your Article Summary
See Latest ArticlesThe diagnosis and treatment of gout
U.S. Pharmacist, 05/21/09
Smith RG – Gout is a monosodium urate, monohydrate crystal deposit disease. This review article provides insights into the pathogenesis of hyperuricemia and gout, risk factors, typical presentation of symptoms, and key diagnostic parameters. Both nonpharmacologic modalities and pharmacologic therapies have been discussed so that greater patient adherence through medication counseling can be achieved.
Adjuvant therapies recommended for gout:- Control weight with daily exercise
- Limit consumption of red meat
- Replace consumption of fish with omega-3 fatty acids
- Consume 1-2 servings of dairy or calcium supplement
- Refrain from food and drinks containing high fructose
- Consume nuts and vegetables daily
- Supplement diet with vit C
- Consumption of coffee may be beneficial
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment of polymyalgia rheumatica
Archives of Internal Medicine, 11/10/09
Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: Clinicopathological features of 24 patients
Journal of Rheumatology, 11/09/09
Bisphosphonate therapy: When not to monitor BMD
The Journal of Family Practice, 11/02/09
Today in Gout and Hyperuricemia...keeping you current
Receive free subspecialty "5-minute updates" via email
Hyperuricemia Is a Mediator of Endothelial Dysfunction and Inflammation in Renal Allograft Recipients
Transplantation Proceedings, 11/02/09
Prescription and comorbidity screening following consultation for acute gout in primary care
Rheumatology, 11/23/09
Common Polymorphisms Influencing Serum Uric Acid Levels Contribute to Susceptibility to Gout, but Not to Coronary Artery Disease
PLoS ONE - Cardiovascular Disorders, 11/10/09